Mary T. Szela
CEO AND PRESIDENT at TriSalus Life Sciences Inc.
Sits on 4 boards. Last updated September 27, 2026
Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 4 boards, counting each seat separately. Longest: Kura Oncology Inc., 3 years.
Kura Oncology Inc.
Director
TriSalus Life Sciences Inc.
Director · CEO and President
Absci Corporation
Director
Averin Capital Acquisition Corp.
Director
Chief executive roles
TriSalus Life Sciences Inc.
· CEO AND PRESIDENT
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | TriSalus Life Sciences Inc. | Grant or award | +3,990 | $3.87 | $15,441 |
| Jun 30, 2026 | Absci Corporation | Open-market purchase | +12,900 | $11.54 | $148,866 |
| Jun 4, 2026 | Absci Corporation | Grant or award | +10,100 | — | — |
| May 15, 2026 | TriSalus Life Sciences Inc. | Open-market purchase | +39,682 | $2.59 | $102,776 |
| Mar 17, 2026 | TriSalus Life Sciences Inc. | Open-market sale | −15,944 | $3.85 | $61,384 |
| Mar 11, 2026 | TriSalus Life Sciences Inc. | Open-market sale | −4,358 | $4.13 | $17,999 |
| Feb 23, 2026 | TriSalus Life Sciences Inc. | Open-market purchase | +30,487 | $4.10 | $124,997 |
| Dec 31, 2025 | TriSalus Life Sciences Inc. | Grant or award | +2,100 | $4.38 | $9,198 |
| Nov 24, 2025 | TriSalus Life Sciences Inc. | Grant or award | +125,000 | — | — |
| Nov 24, 2025 | TriSalus Life Sciences Inc. | Grant or award | +300,000 | — | — |
| Jun 30, 2025 | TriSalus Life Sciences Inc. | Grant or award | +2,848 | $4.23 | $12,047 |
| Feb 18, 2025 | TriSalus Life Sciences Inc. | Grant or award | +21,089 | — | — |
| Jan 30, 2025 | TriSalus Life Sciences Inc. | Open-market purchase | +5,010 | $5.28 | $26,453 |
| Jan 29, 2025 | TriSalus Life Sciences Inc. | Open-market purchase | +5,030 | $5.03 | $25,301 |
| Jan 28, 2025 | TriSalus Life Sciences Inc. | Open-market purchase | +4,716 | $5.12 | $24,146 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.